The Invus Group Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • The Invus Group's estimated annual revenue is currently $15M per year.(i)
  • The Invus Group's estimated revenue per employee is $217,391

Employee Data

  • The Invus Group has 69 Employees.(i)
  • The Invus Group grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M2140%N/AN/A
#2
$7.5M5035%N/AN/A
#3
$11830M250255%$1MN/A
#4
$7.5M415%$48.1MN/A
#5
$15M10015%N/AN/A
#6
N/A150900%N/AN/A
#7
N/A20300%N/AN/A
#8
$7.5M4826%N/AN/A
#9
$3.5M28-7%N/AN/A
#10
$3.5M5351%N/AN/A

Evergreen structure with over $5 billion under management. Offices in New York, Paris, and Hong Kong.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$15M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Invus Group News

2022-04-17 - Biotech venture capital: Top 10 money-raisers of 2021

... Fidelity Management & Research Company, MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group,...

2022-04-06 - Onxeo Reports its Full-Year 2021 Financial Results and ...

- Recurring revenues corresponding to royalties on sales received by the Group pursuant to the agreement with Biogen. In 2020, these revenues...

2022-03-30 - ACTION AGAINST HUNGER WELCOMES FOUR NEW ...

... and CEO of The Invus Group, LLC, a New York-based global investment firm. ... practices of its board of directors and executive team,...

2019-09-08 - US investor joins Achilles Therapeutics £100m Series B round

... by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile Group.

2019-09-07 - UK biotech secures £100m funding for lung cancer trials

Achilles Therapeutics, a UK biotech focusing on personalised immunotherapy for cancer, has closed a £100m Series B funding round that ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M69-12%N/A
#2
$20.1M69-13%N/A
#3
$9M6930%N/A
#4
$9M6919%N/A
#5
$15.5M6919%N/A